Atorus Research

Atorus Research is a clinical analytics company that develops tools, solutions, and services to support data management and biometrics activities in clinical trials. The company works with pharmaceutical and life sciences organizations to automate data workflows, apply open-source and commercial programming technologies, and produce actionable insights from clinical trial data. Atorus serves teams across the drug development process, including statistical programming, data engineering, and clinical operations functions.

Atorus takes a multilingual programming approach, combining publicly available and commercially available platforms — notably R and SAS — to streamline and accelerate drug development. The company builds open-source packages, Shiny applications, and validated infrastructure, and positions itself as a partner for organizations transitioning to or expanding their use of open-source analytics in regulated environments.

Core Products and Platforms

• Ageirein: A platform that received major updates in the Spring release cycle, focused on faster workflows, compliance confidence, and scalable infrastructure for clinical analytics teams.
• OpenVal®: A validated R environment solution that helps organizations implement and maintain validated open-source statistical computing environments. Bayer has publicly noted that OpenVal helped streamline their processes and keep pace with state-of-the-art statistical methodology in open-source packages.
• Atorus Academy: A training and capability-building platform included in the Spring major release, designed to support clinical analytics teams in developing skills and growing alongside the broader product ecosystem.

Key Capabilities

• Clinical data management and biometrics support across the drug development lifecycle
• Automation of clinical trial data workflows to reduce setup time and accelerate time to results
• Development of R packages and Shiny applications for pharmaceutical clients
• Open-source package development, including contributions to packages such as {xportr}
• Validated environment setup and maintenance for regulated clinical programming contexts
• Integration of open-source and commercial coding platforms within a validated, GxP-compliant approach
• Twice-yearly major product release cadence covering all core platforms

Compliance and Deployment

• Solutions are designed for GxP-validated environments, with a focus on reproducibility and regulatory defensibility
• The combined Ageirein, OpenVal, and Atorus Academy system is positioned as a complete capability system for clinical analytics teams operating under compliance requirements
• Atorus publishes guidance on GxP validation topics for clinical programming teams through its blog and content channels

Customers and Partners

• Bayer: Atorus supports Bayer in the setup and maintenance of their validated R environment using OpenVal, as noted by Bayer's VP Global Head of Statistical Programming and Analytics
• A top 5 pharma company (unnamed) engaged Atorus for Shiny app and R package development, citing the company's demonstrated expertise in open-source tools and the pharmaceutical industry
• Additional clients include organizations whose senior statistical programming leadership have cited Atorus's multilingual programming vision as a primary driver for partnership

Atorus Research participates in industry events such as SAS Innovate and maintains an active content program covering clinical analytics, open-source adoption, and GxP compliance topics relevant to statistical programming and data engineering teams in life sciences.